Safety and Efficacy of Oral Levosimendan in People With ALS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
Lancet Neurol 2021 Oct 01;20(10)821-831, M Cudkowicz, A Genge, N Maragakis, S Petri, L van den Berg, VV Aho, T Sarapohja, M Kuoppamäki, C Garratt, A Al-ChalabiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.